DarioHealth (DRIO) Earns Buy Rating from Aegis
DarioHealth (NASDAQ DRIO) traded down $0.06 on Friday, reaching $1.43. 20,800 shares of the company traded hands, compared to its average volume of 76,657. DarioHealth has a 1-year low of $1.33 and a 1-year high of $4.70.
DarioHealth Company Profile
DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.
Receive News & Ratings for DarioHealth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.